Supporting Figures
. Development of a bioluminescent co-chaperone CDC37.
(a) Luminescence kinetics of total cell lysate (about 7 ng diluted in 5 µL of HENG buffer) from transfected 293T cells. Points are means ± SD (n = 5).
(b) Amounts of 3xFLAG-DYRK1A and 3xFLAG-DYRK4 bound on an antibody-coated well, as used in Figure 2c . Bound proteins were quantified with HRP-conjugated antibody against FLAG.
Absorbance values are shown. Amounts of bound 3xFLAG-DYRK1A proteins were almost the same between the samples (within ± 2.0%). Bar graphs show means ± SD (n = 8). (c) Amounts of 3xFLAG-DYRK1A and its mutants bound on an antibody-coated well, as used in Figure 2e .
Bound proteins were quantified, and absorbance values are shown. Amounts of bound 3xFLAG-DYRK1A proteins were almost the same between the samples (within ± 3.5%). Bar graphs show means ± SD (n = 5). (d) DYRK1A proteins did not interact with nanoKAZ. The luminescence intensities of the complexes between nanoKAZ and the 3xFLAG-tagged DYRK1A
Targeting the DYRK1A/CDC37 complex 4 proteins bound on a 96-well plate coated with antibody against FLAG are shown as fold-changes relative to that with EGFP. Bar graphs show means ± SD (n = 5).
Targeting the DYRK1A/CDC37 complex 5 Figure S2 . Development of a bioluminescent chaperone HSP90β.
Amounts of 3xFLAG-DYRK1A proteins bound on an antibody-coated well, as used in Figure 3c .
Bound proteins were quantified with HRP-conjugated antibody against FLAG. Absorbance values are shown. Amounts of bound 3xFLAG-DYRK1A proteins were almost the same between the samples (within ± 4.0%). Bar graphs show means ± SD (n = 4). HEK293 cells were cultured in the presence of CaNDY (2 µM) or ganetespib (100 nM) for four days. Total cell lysates were collected at the indicated time point (day 0-4), and subjected to SDS-PAGE followed by Western blot analysis. 293T cells were transiently transfected with an expression vector for 3xFLAG-DYRK1A. At 24 h after transfection, the cells were pre-treated with 2 µM epoxomicin for 1 h to inhibit proteasome irreversibly, and then treated with/without CaNDY (2 µM) for 8 h. The total cell lysates were subjected to SDS-PAGE followed by Western blot analysis.
Targeting the DYRK1A/CDC37 complex Tables   Table S1. Average of two replicates is shown as percent activity of kinase activity in the presence of CaNDY (1 µM) relative to solvent control (DMSO) DYRK1A, DYRK1B, CLK1, CLK2, and Haspin were inhibited by over 90%. NMR and δ 39.5 for 13 C NMR in DMSO-d 6 ) as an internal reference with coupling constants (J) in hertz (Hz). The abbreviations s, d, t and br signify singlet, doublet, triplet, and broad, respectively.
Synthesis of CaNDY (Z)-5-[(2,3-dihydrobenzofuran-5-yl)methylene]-2-iminothiazolidin-4-one (CaNDY)
Under an argon atomosphere, to a solution of 2,3-dihydrobenzofuran-5-carbaldehyde (296 mg, 2.00 mmol), pseudothiohydantoin (232 mg, 2.00 mmol), and ammonium acetate (77.0 mg, 0.999 mmol) in acetonitirile (2.0 mL) was added acetic acid (120 µL, 2.10 mmol) at room temperature and the mixture was stirred with heating at 80 ºC (bath temperature) for 6 h. After cooling the reaction mixture to room temperature, the precipitate was collected by filtration using a funnel. The collected solid was washed on the funnel with water (3 mL × 4) and diethyl ether (3 mL × 2), and then dried under reduced pressure to afford 3177, 3049, 3028, 2951, 2922, 1667, 1603, 1584, 1497, 1427, 1302, 1271, 1233, 1204, 1150, 760 175.4, 161.1, 130.6, 129.5, 128.8, 126.5, 126.2, 125.7, 109.7, 71.7, 28.7 .
(Z)-5-[(3,4-methylenedioxyphenyl)methylene]-2-iminothiazolidin-4-one (PD0439)
Under an argon atomosphere, to a solution of piperonal (300 mg, 2.00 mmol), pseudothiohydantoin (232 mg, 2.00 mmol), and ammonium acetate (77.0 mg, 0.999 mmol) in acetonitirile (2.0 mL) was added acetic acid (120 µL, 2.10 mmol) at room temperature and the mixture was stirred with heating at 90 ºC (bath temperature) for 6 h. After cooling the reaction mixture to room temperature, the precipitate was collected by filtration using a funnel. The collected solid was washed on the funnel with water (3 mL × 4) and diethyl ether (3 mL × 2), and then dried under reduced pressure to afford 
(Z)-5-[(1H-indol-5-yl)methylene]-2-thioxothiazolidin-4-one (RD0440)
Under an argon atomosphere, to a solution of indole-5-carboxaldehyde (290 mg, 2.00 mmol), rhodanine (266 mg, 2.00 mmol), and ammonium acetate (77.0 mg, 0.999 mmol) in acetonitirile (2.0 mL) was added acetic acid (120 µL, 2.10 mmol) at room temperature and the mixture was stirred with heating at 90 ºC (bath temperature) for 3.5 h. After cooling the reaction mixture to room temperature, the precipitate was collected by filtration using a funnel. The collected solid was washed on the funnel with water (3 mL × 4) and diethyl ether (3 mL × 2), and then dried under reduced pressure to afford (Z)- 
(Z)-5-[(1H-indol-5-yl)methylene]-2-iminothiazolidin-4-one (PD0442)
Under an argon atomosphere, to a solution of indole-5-carboxaldehyde (290 mg, 2.00 mmol), pseudothiohydantoin (232 mg, 2.00 mmol), and ammonium acetate (77.0 mg, 0.999 mmol) in acetonitirile (2.0 mL) was added acetic acid (120 µL, 2.10 mmol) at room temperature and the mixture was stirred with heating at 90 ºC (bath temperature) for 4 h. After cooling the reaction 
